| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$147 |
Quarterly Activities Report
|
31 Jan 2025 8:55AM |
$0.046 |
$0.160 |
risen by
247.83%
|
|
NMR - Price-sensitive ASX Announcement
Full Release
Key Points
- NMR announced the execution of a binding agreement to acquire advanced gold projects including Far Fanning and Blackjack.
- NMR secured full ownership of several mining leases and processing facilities in northern Queensland.
- The Far Fanning Deposit has an inferred resource estimate of 2.3 million tonnes at 1.84 g/t Au.
- Refurbishment of the Blackjack Processing Plant is on track for a production restart in Q3 2025.
- Contractors were engaged for site preparation activities at the Blackjack Plant.
- NMR is focusing on compliance with regulatory bodies and local government for operational readiness.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$10 |
Quarterly Activities Report and Appendix 5B
|
31 Jan 2025 8:55AM |
$0.068 |
$0.097 |
risen by
42.65%
|
|
AXL - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade REE and Gallium discovery at Caladão Project.
- TREO assays up to 28,321ppm recorded.
- 4,000m drilled demonstrating consistent high-grade mineralization.
- Significant surface Gallium mineralization found.
- Fully funded for ongoing exploration with $10.7M cash at hand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$7 |
Change of Company Secretary
|
31 Jan 2025 8:55AM |
$0.018 |
$0.024 |
risen by
33.33%
|
|
| Jatcorp Limited (JAT) ORDINARY FULLY PAID |
Consumer Discretionary |
$26 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:54AM |
$0.495 |
$0.315 |
fallen by
36.36%
|
|
JAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased to $4.68 million, down 57% on the previous corresponding period.
- Gross profit fell to $1.09 million, a 74% decrease year-on-year.
- Net operating cash flow was negative $13,000.
- Sales of Neurio® products suspended in China due to a trademark dispute.
- Jatcorp is pursuing legal avenues in multiple jurisdictions to protect its trademarks.
- The company has onboarded approximately 30 new retail outlets for Neurio® products in Australia.
- Expanded online distribution for Moroka® products in China.
- Five new products launched under the Moroka® brand.
- Manufacturing upgrades completed at ANMA facility to increase production capacity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nimy Resources Limited (NIM) ORDINARY FULLY PAID |
Materials |
$20 |
Quarterly Activities and Cashflow Report
|
31 Jan 2025 8:54AM |
$0.087 |
$0.084 |
fallen by
3.45%
|
|
NIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Focus on drilling and exploration activities at Masson Cu-Ni-PGE Prospect and Block 3 East Gallium Prospect.
- Masson Prospect drilling returned high-grade copper and extended the target zone.
- Block 3 East confirmed high-grade gallium mineralization.
- Completed a $678k capital raise and received an R&D Refund of $1.12m.
- Cash balance of $730k as of 31 December 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$328 |
Update - Notification of buy-back - PE1
|
31 Jan 2025 8:54AM |
$1.340 |
$1.190 |
fallen by
11.19%
|
|
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$204 |
Update - Notification of buy-back - CDM
|
31 Jan 2025 8:53AM |
$0.685 |
$0.685 |
fallen by
0%
|
|
| Novatti Group Limited (NOV) ORDINARY FULLY PAID |
Information Technology |
$14 |
December Quarter Results Presentation
|
31 Jan 2025 8:53AM |
$0.035 |
$0.025 |
fallen by
28.57%
|
|
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$3,798 |
AMP announces details for FY 24 Results
|
31 Jan 2025 8:53AM |
$1.755 |
$1.500 |
fallen by
14.53%
|
|
| Lefroy Exploration Limited (LEX) ORDINARY FULLY PAID |
Materials |
$25 |
December 2024 Quarterly Activities Report
|
31 Jan 2025 8:52AM |
$0.071 |
$0.100 |
risen by
40.85%
|
|
LEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Executed an agreement with BML Ventures for Lucky Strike Gold Project development.
- Lucky Strike Gold Project has a mineral resource estimate of 1.27 Mt at 1.95 g/t Au for 79,600 ounces.
- Mineral resources updated for Burns Central and Mt Martin to unlock value.
- Burns Central defined a high-grade zone of 159,285 ounces of gold.
- Mt Martin's resources increased by 13% to 439,000 ounces of gold.
- Raised $3.3 million in an oversubscribed placement, enhancing cash position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$92 |
OIL December 2024 Quarterly Report and Appendix 4C
|
31 Jan 2025 8:52AM |
$0.160 |
$0.110 |
fallen by
31.25%
|
|
OIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Optiscan reported significant advancements in product development during the December 2024 quarter.
- Collaborative Research Agreement signed with the University of Minnesota for veterinary imaging.
- Prototype of a flexible gastrointestinal scope delivered to Johannes Gutenberg University Mainz.
- Progress made on InVue® product development for clinical evidence generation.
- Increased cash receipts of $0.379 million, with a total of $1 million for the half-year.
- Focus on expanding into the veterinary medicine market with dedicated imaging devices.
- Implemented multiple brand awareness initiatives and attended major industry conferences.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$147 |
Application for quotation of securities - NMR
|
31 Jan 2025 8:52AM |
$0.046 |
$0.160 |
risen by
247.83%
|
|
| Askari Metals Limited (AS2) ORDINARY FULLY PAID |
Materials |
$3 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 8:52AM |
$0.011 |
$0.008 |
fallen by
27.27%
|
|
AS2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquired 100% ownership of the Eyasi Uranium Project.
- Secured a funding package of $1.507 million.
- Surrendered certain exploration licenses in WA.
- Cash and cash equivalents at quarter end were approximately $319,000.
- No substantive mining production activities during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lefroy Exploration Limited (LEX) ORDINARY FULLY PAID |
Materials |
$25 |
December 2024 Quarterly Cashflow Report
|
31 Jan 2025 8:52AM |
$0.071 |
$0.100 |
risen by
40.85%
|
|
LEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was $321,000.
- Net cash from investing activities was $541,000.
- Net cash from financing activities was $2,796,000.
- The report covers the quarter ending December 31, 2024.
- Lefroy Exploration Limited focuses on exploration activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$10 |
Update - Proposed issue of securities - AXL
|
31 Jan 2025 8:51AM |
$0.068 |
$0.097 |
risen by
42.65%
|
|
| Novatti Group Limited (NOV) ORDINARY FULLY PAID |
Information Technology |
$14 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:51AM |
$0.035 |
$0.025 |
fallen by
28.57%
|
|
NOV - Price-sensitive ASX Announcement
Full Release
Key Points
- $12.9m quarterly revenue maintained – up 30% YoY
- Expenses down a further 7% QoQ and 28% YoY to $5.1m
- Q2 FY25 cost reduction program implemented with full benefit from Q3 FY25
- Payments AU/NZ quarterly gross margin up 15% YoY to 49%
- Normalised net operating cash outflow of $2.16m
- $6.25m cash available at end of Q2 FY25
- Expect to achieve positive operating cashflow for the half-year ending June 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gratifii Limited (GTI) ORDINARY FULLY PAID |
Information Technology |
$34 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:51AM |
$0.105 |
$0.090 |
fallen by
14.29%
|
|
GTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Gratifii achieved 110% increase in cash receipts in 2Q FY25.
- Total cash receipts for the year to date reached $25.8 million.
- Recent acquisitions contributed significantly to increased cash flow.
- The company delivered a successful 'Black Friday' rewards program for Coles Online.
- Gratifii's client base expanded to over 20 million accounts.
- Positive EBITDA reported in December following Club Connect acquisition.
- Focus on post-merger integration expected to yield cost savings.
- New product launches and client rollouts planned for 2H FY25.
- Cash position improved to $3.5 million at the end of December 2024.
- Major clients include Virgin Velocity and Members Advantage.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| eMetals Limited (EMT) ORDINARY FULLY PAID |
Materials |
$3 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 8:51AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
EMT - Price-sensitive ASX Announcement
Full Release
Key Points
- Soil sampling confirmed gold mineralization extends over 1,200m at the Mubende Gold Project.
- Negotiations for land access and exploration licenses continue at neighboring tenures.
- 151 hand auger samples were completed at the Meka Project in Western Australia.
- eMetals holds cash and cash equivalents of $3,101,000 at the end of the quarter.
- The company is focused on unlocking value from its high-potential projects in Africa and Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$50 |
Q2FY25 Quarterly Activities Report and Appendix 4C
|
31 Jan 2025 8:51AM |
$0.054 |
$0.019 |
fallen by
64.81%
|
|
DUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported revenue of $10.4 million, up 9% from Q2 FY24.
- Total cash-based costs reduced by 7% in Q2 FY25.
- Targeting breakeven monthly operating cash flow by the end of FY25.
- Board renewed with five new directors appointed.
- Maintained over 230 Communication Service Provider partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$2 |
Quarterly Appendix 4C and Activities Report
|
31 Jan 2025 8:50AM |
$0.017 |
$0.002 |
fallen by
88.24%
|
|
1AD - Price-sensitive ASX Announcement
Full Release
Key Points
- Expanded advisor network engaged to support 'East to West' cellular therapy strategy.
- First non-binding term sheet executed for 'East to West' cellular therapy strategy.
- AD-214 partnering supported by new advisors and data from manufacturing improvements.
- New board members appointed and strategic review nearing completion.
- Cash balance at end of December 2024 was $1.63 million, down from $1.91 million.
- Repayment of the Victorian Government R&D Cash Flow Loan Facility in full during Q2 FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stonehorse Energy Limited (SHE) ORDINARY FULLY PAID |
Energy |
$5 |
Quarterly Activity and Cashflow Report
|
31 Jan 2025 8:50AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
SHE - Price-sensitive ASX Announcement
Full Release
Key Points
- Total production from US portfolio was 49,900 BOE.
- Canadian wells exceeded production forecasts with 29,461 BOE.
- Generated cash receipts of $663,000 for the quarter.
- Ending cash position was $6.5 million.
- Operational challenges included lower natural gas prices and production issues.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$83 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:50AM |
$0.037 |
$0.380 |
risen by
927.03%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Bile tract cancer patient in MAST trial maintains a complete response for over two years.
- Phase 1 onCARlytics trial doses first patient in intratumoural combination arm.
- First Australian site opens for Phase 1b azer-cel trial, recruiting patients.
- Azer-cel research accepted for presentation at the 2025 ASTCT Tandem Meetings.
- Issuance of convertible notes & warrants raises $20 million, with potential for an additional $26 million.
- $11.7 million R&D tax refund received for FY23 in January 2025.
- Imugene has $33.7 million in cash or equivalents at the end of the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Simonds Group Limited (SIO) ORDINARY FULLY PAID |
Consumer Discretionary |
$50 |
Dennis Family Homes Acquisition - Investor Presentation
|
31 Jan 2025 8:49AM |
$0.150 |
$0.140 |
fallen by
6.67%
|
|
SIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of Dennis Family Homes for about $10 million.
- Dennis Family Homes has delivered over 30,000 homes since 1982.
- The acquisition aligns with Simonds’ strategic goals to strengthen its market leadership.
- DFH adds approximately 300 jobs under construction and 500 jobs in the forward order book.
- The acquisition is funded entirely through cash and no shares will be issued.
- Completion of the acquisition is anticipated by early March 2025.
- DFH will provide over 100 new home designs, doubling the options available to customers.
- Projected contribution of $200 million revenue to Simonds in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| xReality Group Ltd (XRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$19 |
Quarterly Activities Report and Appendix 4C - 31 Dec 24
|
31 Jan 2025 8:49AM |
$0.044 |
$0.025 |
fallen by
43.18%
|
|
XRG - Price-sensitive ASX Announcement
Full Release
Key Points
- Record-breaking quarter with highest cash receipts on record.
- Cash receipts of $5.2m for Q2 FY25, 87% increase from pcp.
- Year-to-date cash receipts of $9.5m.
- Annual Recurring Revenue for Operator XR rose to $3.6m, up 19% QoQ.
- Total Contract Value for Operator XR increased to $7.4m, an 80% increase on FY24.
- Positive operational cash flow of $1.5m for the quarter.
- Secured 7 new customers with a total contract value of $1.1m.
- 216 qualified sales opportunities with a total sales pipeline of $27.3m.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fluence Corporation Limited (FLC) ORDINARY FULLY PAID |
Utilities |
$60 |
Fluence Q4 2024 Update Investor Presentation
|
31 Jan 2025 8:49AM |
$0.067 |
$0.055 |
fallen by
17.91%
|
|
FLC - Price-sensitive ASX Announcement
Full Release
Key Points
- Fluence achieved $21.2 million revenue in Q4 2024, doubling its previous quarterly performance.
- The company reported an EBITDA of $1.0 million in Q4 2024.
- FY 2024 revenue growth was 18.8%, excluding impacts from Ivory Coast and SEA & China.
- Fluence secured new orders worth $50 million for FY 2024, with a 23.3% increase from multiple water treatment sectors.
- The backlog at the end of FY 2024 was $88.0 million, with $58.1 million expected to be recognized in FY 2025.
- SPS is a focus area for improving profitability and growth in recurring revenue.
- Guidance for FY 2025 includes revenues of $80-95 million and EBITDA of $3-5 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
